Coca-Cola, Travelers, Philip Morris, Lockheed & more

spike

Take a look at some of the biggest movers in the premarket:

Coca-Cola (KO) – Coca-Cola reported quarterly earnings of 51 cents per share, 7 cents a share above estimates. Revenue also came in above Wall Street forecasts. The company said a shift in consumer habits due to the Covid-19 pandemic would materially impact results this quarter but it is hopeful for a second-half rebound.

Travelers (TRV) – The insurance company earned $2.62 per share for the first quarter, compared to the consensus estimate of $2.85 a share. Revenue was also short of estimates, hit by higher catastrophe losses. Travelers

Read More

Oil moves mixed on easing lockdowns, looming storage shortage

spike

LONDON (Reuters) – Oil prices were mixed on Tuesday as optimism about the easing of coronavirus-related restrictions reassured markets, although traders remained cautious with storage capacities filling up fast and supply cuts not deep enough to counter falling demand.

FILE PHOTO: An oil pump jack pumps oil in a field near Calgary, Alberta, Canada on July 21, 2014. REUTERS/Todd Korol

Brent crude LCOc1 rose 41 cents, or 2%, to $20.40 a barrel at 1006 GMT, following a 6.8% slide on Monday.

U.S. West Texas Intermediate (WTI) crude CLc1 was down 78 cents, or 6%, at $12.00 a barrel. The contract

Read More

Buy now pay later set to disrupt e-commerce payments in APAC

spike

Buy now pay later (BNPL) has emerged as a viable credit option for e-commerce purchases in Asia-Pacific (APAC) as several payment companies are now offering this service in the region.

An analysis of GlobalData’s e-commerce analytics reveals that the APAC e-commerce market is set to grow at a compound annual growth rate of 17.6% from $1.2 trillion in 2016 to $3.6 trillion in 2023.

“The COVID-19 pandemic has not only adversely affected businesses but also consumers’ disposable income. As a result, with rise in demand for consumer financing and growing e-commerce sales buy now and pay later service has emerged

Read More

U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine

spike

BENGALURU/LONDON (Reuters) – The United States has secured almost a third of the first one billion doses planned for AstraZeneca’s experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.

While not proven to be effective against the coronavirus, vaccines are seen by world leaders as the only real way to restart their stalled economies, and even to get an edge over global competitors.

After President Donald Trump demanded a vaccine, the U.S. Department of Health and Human Services agreed to provide up to $1.2 billion to accelerate

Read More